Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 840 participants.

Also called NCT01078051

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 840 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01078051
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
India, Indonesia, South Korea, Taiwan, Thailand (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01078051. Randomized; no masking; primary purpose treatment. Start 2010-03-22 (actual); primary completion 2019-07-22 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)
Intervention (Procedure)
Cypher, xience, Endeavor, Taxus
Intervention (Drug)
optimal medical therapy
Lead sponsor
Seung-Jung Park (class: other)
Collaborator
CardioVascular Research Foundation, Korea (class: other)

Record details

Record id
cardio:ct-nct01078051
Content hash
daf42e265ccf6ed3697b857cf5b57a657a4afdf54471310d914182700081fe03